Genmab A/S (GMAB)
26.44
-0.62
(-2.29%)
USD |
NASDAQ |
May 08, 16:00
26.44
0.00 (0.00%)
After-Hours: 19:25
Genmab Price : 26.44 for May 8, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Novo Nordisk A/S | 46.08 |
| Johnson & Johnson | 221.24 |
| Ascendis Pharma A/S | 238.76 |
| Zealand Pharma A/S | 53.52 |
| Bavarian Nordic A/S | 9.94 |
Price Related Metrics
| PE Ratio | 17.08 |
| PS Ratio | 4.518 |
| Price to Book Value | 2.786 |
| Price to Free Cash Flow | 14.84 |
| Earnings Yield | 5.86% |
| Market Cap | 16.29B |
| Operating PE Ratio | 13.44 |
| Normalized PE Ratio | 15.19 |